NanoVibronix, Inc. (NAOV): Price and Financial Metrics

NanoVibronix, Inc. (NAOV): $3.74

0.24 (+6.86%)

POWR Rating

Component Grades








Add NAOV to Watchlist
Sign Up

NAOV Price/Volume Stats

Current price $3.74 52-week high $15.40
Prev. close $3.50 52-week low $2.94
Day low $3.46 Volume 4,500
Day high $3.74 Avg. volume 53,391
50-day MA $3.56 Dividend yield N/A
200-day MA $6.22 Market Cap 6.22M

NAOV Stock Price Chart Interactive Chart >

NAOV Stock Summary

  • With a market capitalization of $6,308,542, NANOVIBRONIX INC has a greater market value than only 2.45% of US stocks.
  • Revenue growth over the past 12 months for NANOVIBRONIX INC comes in at -55.26%, a number that bests only 4.31% of the US stocks we're tracking.
  • In terms of volatility of its share price, NAOV is more volatile than 98.53% of stocks we're observing.
  • Stocks that are quantitatively similar to NAOV, based on their financial statements, market capitalization, and price volatility, are OTLY, ADSE, AQB, IDXG, and BOXL.
  • Visit NAOV's SEC page to see the company's official filings. To visit the company's web site, go to

NAOV Valuation Summary

  • NAOV's EV/EBIT ratio is -1; this is 108.33% lower than that of the median Healthcare stock.
  • NAOV's price/sales ratio has moved down 36.9 over the prior 97 months.

Below are key valuation metrics over time for NAOV.

Stock Date P/S P/B P/E EV/EBIT
NAOV 2023-05-23 7.9 3.0 -1.2 -1.0
NAOV 2023-05-22 7.6 2.9 -1.2 -1.0
NAOV 2023-05-19 7.0 2.6 -1.1 -0.9
NAOV 2023-05-18 7.4 2.8 -1.1 -0.9
NAOV 2023-05-17 7.6 2.9 -1.2 -1.0
NAOV 2023-05-16 7.8 3.0 -1.2 -1.0

NAOV Growth Metrics

    Its 2 year cash and equivalents growth rate is now at 1252.14%.
  • The 3 year net cashflow from operations growth rate now stands at -42.38%.
  • Its 3 year price growth rate is now at -78.91%.
NAOV's revenue has moved up $1,296,000 over the prior 49 months.

The table below shows NAOV's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 1.629 -6.567 -5.863
2022-06-30 2.031 -5.237 -11.583
2022-03-31 1.864 -5.154 -10.497
2021-12-31 1.695 -4.367 -14.282
2021-09-30 1.01 -4.822 -12.813
2021-06-30 0.661 -4.883 -7.06

NAOV's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • NAOV has a Quality Grade of D, ranking ahead of 5.54% of graded US stocks.
  • NAOV's asset turnover comes in at 0.095 -- ranking 154th of 186 Medical Equipment stocks.
  • NUWE, SIEN, and ATRS are the stocks whose asset turnover ratios are most correlated with NAOV.

The table below shows NAOV's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.095 0.620 20.273
2021-03-31 0.112 0.392 13.158
2020-12-31 0.172 0.343 8.655
2020-09-30 0.300 0.261 -32.726
2020-06-30 0.316 0.193 -30.341
2020-06-30 0.316 0.193 -30.341

NanoVibronix, Inc. (NAOV) Company Bio

NanoVibronix, Inc. operates as a medical device company. The Company focuses on non-invasive biological response-activating devices that target wound healing and pain therapy. NanoVibronix develops medical devices based on its proprietary therapeutic ultrasound technology.

NAOV Latest News Stream

Event/Time News Detail
Loading, please wait...

NAOV Latest Social Stream

Loading social stream, please wait...

View Full NAOV Social Stream

Latest NAOV News From Around the Web

Below are the latest news stories about NANOVIBRONIX INC that investors may wish to consider to help them evaluate NAOV as an investment opportunity.

NanoVibronix Issues Letter to Shareholders

ELMSFORD, N.Y., April 18, 2023--NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today issued a letter to shareholders from its Chief Executive Officer, Brian Murphy, providing a year in review and vision for 2023.

Yahoo | April 18, 2023

NanoVibronix Receives Positive Final Results of Independent Lifecycle Testing of PainShield Prompted by Centers for Medicare and Medicaid Services (CMS)

ELMSFORD, N.Y., March 28, 2023--NanoVibronix, Inc., (NASDAQ: NAOV) (the "Company"), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave ("SAW") technology, today announced that independent life expectancy testing performed by Carmel Labs in Israel confirm that its PainShield met all tested functionalities.

Yahoo | March 28, 2023

NanoVibronix Files Provisional U.S. Patent Application for UroShield Ultra

ELMSFORD, N.Y., March 21, 2023--NanoVibronix, Inc., (NASDAQ: NAOV) (the "Company"), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave ("SAW") technology, today announced it has filed a new provisional patent application with the United States Patent and Trademark Office ("USPTO") entitled "Multiple Frequency Surface Acoustic Waves for Internal Medical Device" (the "Patent Application") related to its UroShield.

Yahoo | March 21, 2023

NanoVibronix Announces Positive Results from Independent Product Trial of UroShield for Patients with a Spinal Cord Injury

ELMSFORD, N.Y., March 14, 2023--NanoVibronix, Inc., (NASDAQ: NAOV) (the "Company"), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced the positive evaluation results for its UroShield device, presented at a recent medical conference by clinicians from the Royal National Orthopaedic Hospital ("RNOH").

Yahoo | March 14, 2023

NanoVibronix Regains Nasdaq Compliance

ELMSFORD, N.Y., March 03, 2023--NanoVibronix, Inc. (NASDAQ: NAOV) (the "Company"), a medical device company that produces the UroShield® and PainShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that on February 28, 2023, the Company received official notice from The Nasdaq Stock Market LLC that the Company has evidenced compliance with all applicable criteria for continued listing on The Nasdaq Capital Market, including the $1.00 bid price requirement.

Yahoo | March 3, 2023

Read More 'NAOV' Stories Here

NAOV Price Returns

1-mo 2.19%
3-mo -5.56%
6-mo -54.39%
1-year -72.80%
3-year -91.61%
5-year -96.10%
YTD -25.79%
2022 -75.77%
2021 36.11%
2020 -73.19%
2019 -21.27%
2018 -22.65%

Continue Researching NAOV

Here are a few links from around the web to help you further your research on NanoVibronix Inc's stock as an investment opportunity:

NanoVibronix Inc (NAOV) Stock Price | Nasdaq
NanoVibronix Inc (NAOV) Stock Quote, History and News - Yahoo Finance
NanoVibronix Inc (NAOV) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!